Endeavor

New Immunotherapy Could Be on the Horizon for Ovarian Cancer

Understanding tertiary lymphoid structures could unlock new treatments for a variety of cancers

Ocala Royal Dames Fund $1 Million for Moffitt Cancer Research

For more than three decades, a group of Ocala-area women have worked tirelessly and methodically to raise money for cancer research.

Can Higher Doses of Radiation Be Effective for Soft Tissue Sarcoma?

Acute toxicity can present challenges like skin redness and infections

Infiltrating and Destroying Solid Tumors

Engineering a patient’s immune cells to attack cancer offers new hope for solid tumor patients

DRIVE Study Offers New Treatment Options for Vulvar Cancer

Data shows radiation therapy as effective first line treatment

Expanding Targets for Cell Therapy

Thanks to the infrastructure in place for blood cancers, Moffitt is ready to expand CAR T-cell therapy to solid tumors

Combining Targeted Radiotherapy with Immunotherapy May Improve Outcomes for Cervical Cancer Patients

Interim results from phase 2 clinical trial reveal responses to combination therapy

Can Bridging Radiation Therapy Increase Success of CAR T?

Moffitt study finds radiation prior to CAR T may increase survival in high-risk patients

Moffitt Radiation Oncology Experts Share the Latest in Treatment and Research

The American Society for Radiation Oncology annual meeting is the largest conference of its kind in the world